A radiomics feature-based nomogram to predict telomerase reverse transcriptase promoter mutation status and the prognosis of lower-grade gliomas

Radiomics Features Predict Telomerase Reverse Transcriptase Promoter Mutations in World Health Organization Grade II Gliomas via a Machine-Learning Approach

(2021) Shengyu Fang et al.   Frontiers in Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

Perfusion parameters derived from MRI for preoperative prediction of IDH mutation and MGMT promoter methylation status in glioblastomas

(2021) Jun Lu et al.   MAGNETIC RESONANCE IMAGING

Programmable base editing of mutated TERT promoter inhibits brain tumour growth

(2020) Xinjian Li et al.   NATURE CELL BIOLOGY

ALT: A Multi-Faceted Phenomenon

(2020) Aurore Sommer et al.   Genes

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies

(2020) Thomas Kent et al.   Frontiers in Oncology

Correlation between IDH, ATRX, and TERT promoter mutations in glioma

(2020) Shigeo Ohba et al.   Brain Tumor Pathology

Conventional magnetic resonance imaging–based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas

(2020) Chendan Jiang et al.   NEURORADIOLOGY

Noninvasive Prediction of TERT Promoter Mutations in High-Grade Glioma by Radiomics Analysis Based on Multiparameter MRI

(2020) Hongan Tian et al.   Biomed Research International

Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas

(2020) Yae Won Park et al.   EUROPEAN RADIOLOGY

MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma

(2019) Jana Ivanidze et al.   JOURNAL OF NEUROIMAGING

Predicting TERT promoter mutation using MR images in patients with wild-type IDH1 glioblastoma

(2019) K. Yamashita et al.   Diagnostic and Interventional Imaging

Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study

(2019) Ankur Goyal et al.   Abdominal Radiology

An independently validated survival nomogram for lower-grade glioma

(2019) Haley Gittleman et al.   NEURO-ONCOLOGY

Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas

(2019) Chendan Jiang et al.   EUROPEAN JOURNAL OF RADIOLOGY

Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas

(2018) Cemaliye B. Akyerli et al.   JOURNAL OF NEUROSURGERY

Histogram Analysis Parameters Apparent Diffusion Coefficient for Distinguishing High and Low-Grade Meningiomas: A Multicenter Study

(2018) Alexey Surov et al.   Translational Oncology

Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner

(2018) Andrew Mancini et al.   CANCER CELL

Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study

(2018) Qiuyu Wang et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas

(2018) Hideyuki Arita et al.   Scientific Reports

Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas

(2018) Bill H Diplas et al.   NEURO-ONCOLOGY

NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017

(2017) Louis Burt Nabors et al.   Journal of the National Comprehensive Cancer Network

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

(2017) Michael Weller et al.   LANCET ONCOLOGY

Radiomics: the bridge between medical imaging and personalized medicine

(2017) Philippe Lambin et al.   Nature Reviews Clinical Oncology

New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma

(2017) Tunc F. Ersoy et al.   NEURORADIOLOGY

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

(2015) Patrick J. Killela et al.   Oncotarget

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

(2013) P. J. Killela et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gross Total Resection of Glioma with the Intraoperative Fluorescence-guidance of Fluorescein Sodium

(2012) Bo Chen et al.   International Journal of Medical Sciences